Table 2 Number of incident cancers (annual rate per 1000 patients) by CKD status and cancer site
|  | CKD status (CKD EPI-estimated GFR (mL/min/1.73 m2)) | Dialysis (n = 3023) | All (n = 32057) | |||
|---|---|---|---|---|---|---|
Greater than 75 (n = 9594) | 60 to 75 (n = 6681) | 45 to 60 (n = 4931) | Less than 45 (n = 7828) | |||
Total person years | 48216 | 41013 | 34630 | 35011 | 11948 | 170819 |
All sites | 596 (13.9) | 621 (14.0) | 580 (15.7) | 619 (18.5) | 210 (22.2) | 2626 (15.4) |
Oral cavity and pharynx | 12 (0.3) | 12 (0.3) | 12 (0.3) | 11 (0.3) | 9 (0.6) | 56 (0.3) |
Digestive | 172 (4.0) | 177 (3.8) | 156 (4.0) | 147 (4.3) | 54 (6.6) | 706 (4.1) |
Respiratory | 88 (1.9) | 86 (2.0) | 59 (1.7) | 63 (1.9) | 26 (2.9) | 322 (1.9) |
Melanomas | 16 (0.4) | 24 (0.5) | 43 (1.2) | 40 (1.2) | 7 (0.8) | 130 (0.8) |
Breast | 60 (1.4) | 69 (1.8) | 74 (1.7) | 60 (1.7) | 14 (1.2) | 277 (1.6) |
Female genital | 17 (0.4) | 20 (0.4) | 19 (0.7) | 23 (0.7) | 8 (0.9) | 87 (0.5) |
Prostate | 79 (1.7) | 80 (1.9) | 72 (2.1) | 85 (2.8) | 16 (1.9) | 332 (1.9) |
Male genital | 1 (0.0) | 0 (0.0) | 1 (0.0) | 2 (0.1) | 1 (0.1) | 5 (0.0) |
Soft tissue/connective tissue | 3 (0.1) | 3 (0.1) | 5 (0.1) | 12 (0.4) | 0 (0.0) | 23 (0.1) |
Urinary tract | 40 (1.0) | 30 (0.7) | 35 (1.3) | 83 (2.5) | 40 (4.1) | 228 (1.3) |
Central nervous system | 11 (0.3) | 15 (0.3) | 9 (0.2) | 8 (0.2) | 2 (0.3) | 45 (0.3) |
Endocrine | 5 (0.1) | 2 (0.1) | 5 (0.2) | 5 (0.2) | 12 (0.7) | 29 (0.2) |
Haematological | 47 (1.0) | 53 (1.1) | 43 (1.0) | 42 (1.2) | 16 (1.5) | 201 (1.2) |
Multiple primary sites | 5 (0.2) | 14 (0.3) | 14 (0.3) | 9 (0.2) | 0 (0.0) | 42 (0.2) |
Unknown origin | 17 (0.4) | 10 (0.2) | 10 (0.2) | 18 (0.6) | 5 (0.7) | 60 (0.4) |
Bone and cartilage | 2 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.0) |
Others | 8 (0.2) | 10 (0.3) | 7 (0.3) | 0 (0.0) | 0 (0.0) | 25 (0.1) |
Site data not available | 13 | 16 | 16 | 11 | 0 | 56 |